Tue, 13 August 2013
ASCO Lung Cancer Highlights, Part 4: Exploring the Role of Trimodality Therapy for Stage III NSCLC (audio)
Dr. David Gerber, University of Texas-Southwestern, reviews a Swiss study comparing tri-modality therapy with chemoradiation followed by surgery to chemo followed by surgery for stage IIIA NSCLC.
Direct download: GRACEcast-162_Lung-Audio_Trimodality_Swiss_Study_Stage_III_NSCLC.mp3
Category:Lung-Cancer-Audio -- posted at: 5:03pm PDT